NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
6.20
-0.33 (-5.05%)
Jul 29, 2026, 10:09 AM EDT - Market open
NeurAxis Employees
NeurAxis had 24 employees as of December 31, 2025. The number of employees increased by 3 or 14.29% compared to the previous year.
Employees
24
Change (1Y)
3
Growth (1Y)
14.29%
Revenue / Employee
$178,396
Profits / Employee
-$336,406
Market Cap
76.78M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 24 | 3 | 14.29% | 24 | 0 |
| Dec 31, 2024 | 21 | 2 | 10.53% | 21 | 0 |
| Dec 31, 2023 | 19 | 1 | 5.56% | 19 | 0 |
| Dec 31, 2022 | 18 | - | - | 17 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Heron Therapeutics | 128 |
| Inovio Pharmaceuticals | 112 |
| Adicet Bio | 102 |
| Gain Therapeutics | 21 |
| Cognition Therapeutics | 14 |
| Rallybio | 9 |
| Alterity Therapeutics | 9 |
NRXS News
- 1 day ago - NeurAxis to Host Second Quarter 2026 Results and Business Update Call on Tuesday, August 11, 2026 - GlobeNewsWire
- 5 days ago - Neuraxis files to sell 1.92M shares of common stock for holders - TheFly
- 6 days ago - NeurAxis Registration statement: Registration filing - Filings
- 2 months ago - NeurAxis Transcript: Lytham Partners Spring 2026 Investor Conference - Transcripts
- 2 months ago - NeurAxis Slides: Investor presentation - Filings
- 2 months ago - NeurAxis Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - NeurAxis Quarterly report: Q1 2026 - Filings
- 2 months ago - NeurAxis Earnings release: Q1 2026 - Filings